|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 47.71 EUR | -2.87% |
|
-6.12% | +28.91% |
| 07-15 | Bayer, RAGT Enter Licensing Deal to Launch Hybrid Wheat Seeds | MT |
| 07-14 | ORIC Pharmaceuticals Starts Phase 3 Trial of Rinzimetostat in Metastatic Prostate Cancer | MT |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bullish | Bullish | Bullish |
| Resistance | 53.36 | 53.36 | 53.36 |
| Spread/Res. | -10.59% | -10.59% | -10.59% |
| Spread/Supp. | +9.83% | +15.35% | +31.94% |
| Support | 43.44 | 41.36 | 36.16 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- BAYN Stock
- Charts Bayer AG
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
